Group 1 - Novavax, Inc. will report its first quarter 2025 financial results and operational highlights on May 8, 2025, at 8:30 a.m. ET [1] - The conference call can be accessed via a dedicated URL and includes both domestic and international dial-in numbers [1][5] - A replay of the conference call will be available from May 8, 2025, at 11:30 a.m. ET until May 15, 2025, with specific dial-in numbers and a passcode provided for access [2] Group 2 - Novavax focuses on addressing significant health challenges through its expertise in vaccines and advanced technology platforms, including protein-based nanoparticles and the Matrix-M® adjuvant [3] - The company's growth strategy emphasizes forming diversified partnerships through out-licensing of its technology and vaccine assets, aiming to enhance its early-stage pipeline [3]
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025